TITLE

Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processing

AUTHOR(S)
Hanada, Ken-ichi; Yang, James C.
PUB. DATE
June 2005
SOURCE
Journal of Molecular Medicine;Jun2005, Vol. 83 Issue 6, p420
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In the past 15 years, the molecular identification of antigens that can mediate the killing of tumor cells by T cells has been vigorously pursued. Molecular identification of tumor-associated antigens not only provided the means to activate or monitor anti-tumor immunity, but also gave insights into new and unexpected biochemical processes that are taking place within cells. Post-translational splicing, a phenomenon previously identified only in lower organisms or plants, has recently been added to the list of atypical processes generating proteins in humans. The proteasome, whose main function is to degrade intracellular proteins, appears to catalyze this splicing reaction. The discovery of post-translational splicing has immediate and important implications for the complexity of the major histocompatibility complex (MHC) class I peptide repertoire and for the immune recognition of self- and foreign peptides.
ACCESSION #
17312154

 

Related Articles

  • Antigen-recognition properties of murine ϒδ T cells. Chien, Y.-H.; Hampl, J. // Springer Seminars in Immunopathology;2000, Vol. 22 Issue 3, p239 

    Explores the antigen-recognition properties of murine gamma/delta T cells. Structural differences between murine T10/T22 ligands of peripheral gamma/delta T cells and classical major histocompatibility complex class I molecules; Possible contact sites of the G8 T cell receptor with T10;...

  • Ubiquitylation gives DCs the professional edge. Minton, Kirsty // Nature Reviews Immunology;Nov2006, Vol. 6 Issue 11, p795 

    The article describes the mechanism for the upregulation of cell-surface expression of MHC class II molecules during the maturation of dentritic cells. The study indicated that the cell-surface expression is controlled by ubiquitylation of MHC class II molecules. Therefore, the author suggested...

  • Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp10025–33 Peptides. Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Identification and quantification of immunogenic peptides and tumor-derived epitopes presented on MHC-I molecules are essential for basic studies and vaccines generation. Although lymphocytes derived from transgenic mice can serve as sensitive detectors of processes of antigen presentation and...

  • Characterization of MHC Ligands for Peptide Based Tumor Vaccination. Klug, Felix; Miller, Matthias; Schmidt, Hans-Henning; Stevanović, Stefan // Current Pharmaceutical Design;10/1/2009, Vol. 15 Issue 28, p3221 

    Short peptides derived from cellular proteins may escape complete destruction during protein catabolism and finally serve as a showcase in the immune system. Exposed at the cell surface to scrutiny by T cells, MHC:peptide complexes mediate a highly specific and immediate information transfer...

  • Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response. Kissick, Haydn T.; Sanda, Martin G.; Dunn, Laura K.; Arredouani, Mohamed S. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer...

  • The TCR/CD3 Complex: Opening the Gate to Successful Vaccination. Portolés, Pilar; Rojo, Jose M. // Current Pharmaceutical Design;10/1/2009, Vol. 15 Issue 28, p3290 

    The success of vaccination is directly or indirectly based on the specificity of antigen recognition by T lymphocytes, their efficient activation and expansion, and the generation of vaccine-specific effector and memory cells. These traits are largely dependent on the correct assembly and...

  • Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Mester, Gabor; Hoffmann, Vanessa; Stevanović, Stefan // Cellular & Molecular Life Sciences;May2011, Vol. 68 Issue 9, p1521 

    Short peptides derived from intracellular proteins and presented on MHC class I molecules on the cell surface serve as a showcase for the immune system to detect pathogenic or malignant alterations inside the cell, and the sequencing and analysis of the presented peptide pool has received...

  • Attenuated T Cell Responses to a High-Potency Ligand In Vivo. Corse, Emily; Gottschalk, Rachel A.; Krogsgaard, Michelle; Allison, James P. // PLoS Biology;Sep2010, Vol. 8 Issue 9, p1 

    αβ T cell receptor (TCR) recognition of foreign peptides bound to major histocompatibility complex (pMHC) molecules on the surface of antigen presenting cells is a key event in the initiation of adaptive cellular immunity. In vitro, high-affinity binding and/or long-lived interactions...

  • Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cells. Venkatraman, Prasanna; Nguyen, Tina T.; Sainlos, Matthieu; Bilsel, Osman; Chitta, Sriram; Imperiali, Barbara; Stern, Lawrence J. // Nature Chemical Biology;Apr2007, Vol. 3 Issue 4, p222 

    A crucial step in the immune response is the binding of antigenic peptides to major histocompatibility complex (MHC) proteins. Class II MHC proteins present their bound peptides to CD4+ T cells, thereby helping to activate both the humoral and the cellular arms of the adaptive immune response....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics